| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 112.63B | 105.30B | 103.47B | 96.50B | 87.61B |
| Gross Profit | 72.40B | 65.81B | 63.06B | 52.77B | 46.97B |
| EBITDA | 38.07B | 32.00B | 30.76B | 22.49B | 19.69B |
| Net Income | 33.76B | 29.70B | 29.42B | 20.34B | 16.86B |
Balance Sheet | |||||
| Total Assets | 221.51B | 195.99B | 185.92B | 172.76B | 153.64B |
| Cash, Cash Equivalents and Short-Term Investments | 167.00B | 137.58B | 126.72B | 117.46B | 97.53B |
| Total Debt | 6.39B | 12.82B | 20.48B | 28.46B | 21.69B |
| Total Liabilities | 56.34B | 53.50B | 57.84B | 63.89B | 54.37B |
| Stockholders Equity | 160.36B | 138.69B | 124.29B | 104.73B | 95.33B |
Cash Flow | |||||
| Free Cash Flow | 48.39B | 38.40B | 31.06B | 25.07B | 21.82B |
| Operating Cash Flow | 49.43B | 39.68B | 35.33B | 27.71B | 24.93B |
| Investing Cash Flow | -32.22B | 17.92B | -17.04B | -7.37B | -7.08B |
| Financing Cash Flow | -19.74B | -27.34B | -21.47B | -10.24B | -12.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$3.45B | 7.47 | 17.91% | 3.82% | -4.19% | 0.41% | |
73 Outperform | HK$528.84B | 18.22 | 22.14% | 2.22% | 6.96% | 14.02% | |
69 Neutral | HK$32.67B | 18.73 | 44.75% | 1.18% | 14.94% | 84.38% | |
67 Neutral | HK$33.73B | 9.26 | 8.02% | 0.48% | -6.10% | 25.65% | |
66 Neutral | HK$72.66B | 62.43 | 8.04% | ― | 13.20% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
54 Neutral | HK$1.88B | 16.23 | 6.38% | ― | -27.41% | 138.08% |